Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study. (abre una nueva ventana)

Abdelrazik N, Fouda M

Fuente‎: Hematology 2007;12(6):533-41.

Indexado en‎: PubMed 17852440

DOI‎: 10.1080/10245330701521572

https://www.ncbi.nlm.nih.gov/pubmed/17852440 (abre una nueva ventana)

Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial. (abre una nueva ventana)

Cabanillas ME, Kantarjian H, Thomas DA, Mattiuzzi GN, Rytting ME, Bruera E, Xiao L, Bekele BN, Foudray MC, Cortes JE.

Fuente‎: Cancer 2012;118(3):848-55.

Indexado en‎: PubMed 21751205

DOI‎: 10.1002/cncr.26341

https://www.ncbi.nlm.nih.gov/pubmed/21751205 (abre una nueva ventana)

Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment. (abre una nueva ventana)

Corapcioglu F, Aksu G, Basar EZ, Demirel A, Oncel S, Mutlu A

Fuente‎: Pediatr Hematol Oncol 2008;25(6):509-21.

Indexado en‎: PubMed 18728970

DOI‎: 10.1080/08880010802235132

https://www.ncbi.nlm.nih.gov/pubmed/18728970 (abre una nueva ventana)

Recombinant human erythropoietin beta: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients. (abre una nueva ventana)

Durmaz O, Demirkaya M, Sevinir B

Fuente‎: Pediatr Hematol Oncol 2011;28(6):461-8.

Indexado en‎: PubMed 21707225

DOI‎: 10.3109/08880018.2011.570857

https://www.ncbi.nlm.nih.gov/pubmed/21707225 (abre una nueva ventana)

Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. (abre una nueva ventana)

Engert A, Josting A, Haverkamp H, Villalobos M, Lohri A, Sökler M, Zijlstra J, Sturm I, Topp MS, Rank A, Zenz T, Vogelhuber M, Nogova L, Borchmann P, Fuchs M, Flechtner HH, Diehl V.

Fuente‎: J Clin Oncol 2010;28(13):2239-45.

Indexado en‎: PubMed 20368566

DOI‎: 10.1200/JCO.2009.25.1835

https://www.ncbi.nlm.nih.gov/pubmed/20368566 (abre una nueva ventana)

Treatment patterns and outcomes in management of solid cancer patients suffering from anemia in Penang hospital. (abre una nueva ventana)

Hassan BA, Yusoff ZB

Fuente‎: Asian Pac J Cancer Prev 2011;12(6):1573-6.

Indexado en‎: PubMed 22126501

https://www.ncbi.nlm.nih.gov/pubmed/22126501 (abre una nueva ventana)

Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia. (abre una nueva ventana)

Hernandez E, Ganly P, Charu V, Dibenedetto J, Tomita D, Lillie T, Taylor K; ARANESP 20030232 Study Group

Fuente‎: Curr Med Res Opin 2009;25(9):2109-20.

Indexado en‎: PubMed 19601709

DOI‎: 10.1185/03007990903084164

https://www.ncbi.nlm.nih.gov/pubmed/19601709 (abre una nueva ventana)

Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy. (abre una nueva ventana)

Hinds PS, Hockenberry M, Feusner J, Hord JD, Rackoff W, Rozzouk BI

Fuente‎: J Support Oncol 2005;3(6 Suppl 4):10-1.

Indexado en‎: PubMed 16355549

https://www.ncbi.nlm.nih.gov/pubmed/16355549 (abre una nueva ventana)

The efficacy of recombinant human erythropoietin in treatment chemotherapy induced anemia in children diagnosed with a solid cancer. (abre una nueva ventana)

Hiradfar A, Banihosseinian M

Fuente‎: Iran J Ped Hematol Oncol 2014;4(4):151-9.

Indexado en‎: PubMed 25598955

https://www.ncbi.nlm.nih.gov/pubmed/25598955 (abre una nueva ventana)

2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer. (abre una nueva ventana)

Marec-Berard P, Chastagner P, Kassab-Chahmi D, Casadevall N, Marchal C, Misset JL, Ray-Coquard I.

Fuente‎: Pediatr Blood Cancer 2009;53(1):7-12.

Indexado en‎: PubMed 19229970

DOI‎: 10.1002/pbc.21953

https://www.ncbi.nlm.nih.gov/pubmed/19229970 (abre una nueva ventana)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (abre una nueva ventana)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Fuente‎: Cancer 2013;119(1):107-14.

Indexado en‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (abre una nueva ventana)

Erythropoietic growth factors for children with cancer: a systematic review of the literature. (abre una nueva ventana)

Mystakidou K, Potamianou A, Tsilika E

Fuente‎: Curr Med Res Opin 2007;23(11):2841-7.

Indexado en‎: PubMed 17910805

DOI‎: 10.1185/030079907x242601

https://www.ncbi.nlm.nih.gov/pubmed/17910805 (abre una nueva ventana)

Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. (abre una nueva ventana)

Razzouk BI, Hord JD, Hockenberry M, Hinds PS, Feusner J, Williams D, Rackoff WR

Fuente‎: J Clin Oncol 2006;24(22):3583-9.

Indexado en‎: PubMed 16877725

DOI‎: 10.1200/JCO.2005.03.4371

https://www.ncbi.nlm.nih.gov/pubmed/16877725 (abre una nueva ventana)

The role of recombinant erythropoietin in childhood cancer. (abre una nueva ventana)

Shankar AG

Fuente‎: Oncologist 2008;13(2):157-66.

Indexado en‎: PubMed 18305061

DOI‎: 10.1634/theoncologist.2007-0126

https://www.ncbi.nlm.nih.gov/pubmed/18305061 (abre una nueva ventana)

Efficacy and safety of iorEPOCIM for chemotherapy- or radiotherapy-induced anemia in pediatric cancer patients. (abre una nueva ventana)

Vargas A, Mendoza I, Uranga R, González A, Martínez L, Caballero I, Piedra P, Saurez G, Verdecia M, Cabanas R

Fuente‎: MEDICC Rev 2010;12(3):27-31.

Indexado en‎: PubMed 20697335

DOI‎: 10.37757/MR2010.V12.N3.7

https://www.ncbi.nlm.nih.gov/pubmed/20697335 (abre una nueva ventana)

A single institutional experience: is epoetin alpha effective in anemic children with cancer? (abre una nueva ventana)

Yilmaz D, Cetingül N, Kantar M, Oniz H, Kansoy S, Kavakli K

Fuente‎: Pediatr Hematol Oncol 2004;21(1):1-8.

Indexado en‎: PubMed 14660300

https://www.ncbi.nlm.nih.gov/pubmed/14660300 (abre una nueva ventana)

Single dose darbepoetin alfa is useful in reducing red cell transfusions in leukemic children receiving chemotherapy. (abre una nueva ventana)

Zachariah M, Elshinawy M, Alrawas A, Bashir W, Elbeshlawi I, Tony S, Wali Y

Fuente‎: Pediatr Hematol Oncol 2014;31(5):442-7.

Indexado en‎: PubMed 24088186

DOI‎: 10.3109/08880018.2013.824527

https://www.ncbi.nlm.nih.gov/pubmed/24088186 (abre una nueva ventana)

Early epoetin alfa treatment in children with solid tumors. (abre una nueva ventana)

Zoubek A, Kronberger M

Fuente‎: Med Pediatr Oncol 2002;39(4):459-62.

Indexado en‎: PubMed 12203664

DOI‎: 10.1002/mpo.10186

https://www.ncbi.nlm.nih.gov/pubmed/12203664 (abre una nueva ventana)

Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. (abre una nueva ventana)

Crary SE, Hall K, Buchanan GR.

Fuente‎: Pediatr Blood Cancer 2011;56(4):615-9.

Indexado en‎: PubMed 21298748

DOI‎: 10.1002/pbc.22930

https://www.ncbi.nlm.nih.gov/pubmed/21298748 (abre una nueva ventana)

Intravenous iron sucrose for children with iron deficiency anemia. (abre una nueva ventana)

Kaneva K, Chow E, Rosenfield CG, Kelly MJ

Fuente‎: J Pediatr Hematol Oncol 2017;39(5):e259-62.

Indexado en‎: PubMed 28562517

DOI‎: 10.1097/MPH.0000000000000879

https://www.ncbi.nlm.nih.gov/pubmed/28562517 (abre una nueva ventana)

Advances in Pediatric Intravenous Iron Therapy. (abre una nueva ventana)

Mantadakis E.

Fuente‎: Pediatr Blood Cancer 2016;63(1):11-6.

Indexado en‎: PubMed 26376214

DOI‎: 10.1002/pbc.25752

https://www.ncbi.nlm.nih.gov/pubmed/26376214 (abre una nueva ventana)

The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. (abre una nueva ventana)

Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B.

Fuente‎: Cochrane Database Syst Rev 2016;(2):CD009624.

Indexado en‎: PubMed 26845108

DOI‎: 10.1002/14651858.CD009624.pub2

https://www.ncbi.nlm.nih.gov/pubmed/26845108 (abre una nueva ventana)

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. (abre una nueva ventana)

Pedrazzoli P, Farris A, Del Prete S, Del Gaizo F, Ferrari D, Bianchessi C, Colucci G, Desogus A, Gamucci T, Pappalardo A, Fornarini G, Pozzi P, Fabi A, Labianca R, Di Costanzo F, Secondino S, Crucitta E, Apolloni F, Del Santo A, Siena S.

Fuente‎: J Clin Oncol 2008;26(10):1619-25.

Indexado en‎: PubMed 18375891

DOI‎: 10.1200/JCO.2007.12.2051

https://www.ncbi.nlm.nih.gov/pubmed/18375891 (abre una nueva ventana)

Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron. (abre una nueva ventana)

Plummer ES, Crary SE, McCavit TL, Buchanan GR

Fuente‎: Pediatr Blood Cancer 2013;60(11):1747-52.

Indexado en‎: PubMed 23832487

DOI‎: 10.1002/pbc.24676

https://www.ncbi.nlm.nih.gov/pubmed/23832487 (abre una nueva ventana)